Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

Although outcome following bevacizumab among recurrent grade IV malignant glioma patients is documented as poor by several analyses, outcome for recurrent grade III patients following bevacizumab therapy has not been specifically evaluated. We performed a pooled analysis of 96 recurrent grade III ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reardon, David A., Herndon, James E., Peters, Katherine, Desjardins, Annick, Coan, April, Lou, Emil, Sumrall, Ashley, Turner, Scott, Sathornsumetee, Sith, Rich, Jeremy N., Boulton, Susan, Lipp, Eric S., Friedman, Henry S., Vredenburgh, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403724/
https://ncbi.nlm.nih.gov/pubmed/21997879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-011-0740-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados